health

INDIA: Patents Case Challenges the World

Ann De Ron

BRUSSELS, Nov 2 2006 (IPS) – Médecins Sans Frontières and other groups campaigning for access to affordable medicines in developing countries are closely following a case filed by the Swiss pharmaceuticals giant Novartis against Indian patent law.
A decision in this case can create an important precedent, with consequences that go far beyond India. If the Novartis challenge against the Indian patent law is successful, patients worldwide who depend on India for affordable medicines risk becoming victims, Ellen t Hoen, policy director with the Médecins Sans Frontières (MSF) Campaign for Access to Essential Medicines told IPS.

Eighty-four percent of AIDS medicines we currently use for patients in more than 40 countries come from India, Ellen t Hoen said. Because of the lower prices we can treat 60,000 people. If we would use only patented medicines this would be a lot less. And this is only one example.

As of 2005, India is bound by World Trade Organisation (WTO) rules in the agreement on Trade-Related Aspects of Intellectual Property (TRIPS). But India remains one of the largest producers of generic medicines. Until 2005 it only recognised patents for a production process, not for a product, and this was good for Indian producers of generic medicines that develop their own process to produce a known medicine.

India simply does not obey TRIPS, and our company has the right to make profit from its investment in research there too, Novartis spokesman in Belgium Xavier Thiriar told IPS. India will be one of the largest markets in the world in terms of population, and they export a lot too.

Thiriar acknowledges that access to basic medicines can be a problem, but says that Novartis cooperates with MSF and gives free medicines worth large amounts of money.
But discounts and free medicines from companies are not a structural solution for the pressing lack of available medicines, Sigrid Sterckx, professor of ethics, and expert on patents at the University of Ghent in Belgium told IPS.

And India does obey TRIPS, argues Ellen t Hoen of MSF. India refuses patent applications for medicines for trivial improvements of known molecules. That is allowed under TRIPS.

Such trivial improvements can for instance involve removing a limy taste, says Sterckx. I find it morally evident that this should not be patentable. But in Europe and the U.S. this sort of change is sufficient to get a new patent. The medicine is then sold more expensively, and people are made to think it is a real improvement.

The challenge to India s patent law arose when an Indian patent bureau rejected a patent application for the Novartis cancer drug Gleevec on the argument that the company wanted to patent a trivial improvement .

Thiriar denies that Novartis has ever patented trivial improvements, whether in India or elsewhere.

But more is at stake here than the question whether the Gleevec version Novartis wanted to patent in India is innovative or not. Novartis not only went to court to fight the Gleevec case, but challenged the entire Indian patent law. The company has sued the Indian government, Indian producers of generic medicines and an Indian group of cancer patients before the Chennai High Court in southern India.

The case came up first Sep. 26. A new hearing is expected later in November.

This is a very dangerous precedent for India and other countries, Leena Menghaney of MSF India told IPS on phone. Now it s about Gleevec, but later on it will be about all other medicines.

The patent law cannot be allowed to weaken, Menghaney insists. We cannot follow the western system people here have no health insurance, and when they get ill they may have to sell their house, their jewellery.

MSF and 16 other organisations are asking Novartis to withdraw the case. One of the signatories to an open letter the groups have written to Novartis is former Swiss president Ruth Dreifuss, who also chairs the World Health Organisation Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH).

Sterckx compares the current court case with the case that major pharmaceutical companies filed in 1998 against the government of Nelson Mandela in South Africa. They demanded that South Africa abolish a law that made it possible to produce or import affordable versions of patented AIDS medicines. They finally withdrew the case in 2001.

It was a total PR (public relations) disaster for the pharmaceutical industry, Sterckx said. Have they learned nothing from the debacle of those days?

11022042 ORP009 NNNN

 

Related Posts

One Of The Most Popular Books For Aspiring Game Designers Is Getting A New Edition

If you’ve ever dreamed of making a game, you’ll want to check out Level Up: The Guide to Great Video Game Design Come from malaysia online casino . Written by veteran game developer Scott Rogers, the book is lauded as one of the best resources for learning game design, covering everything from starting your very first project to project management and monetization. A new edition of the book is launching soon on December 5 that will expand on the original with new chapters and insights from Rogers, and preorders are available now.

If you’re looking to build up a library of game development books, there are several other titles worth grabbing, many of which are on sale right now. The Art of Game Design: A Book of Lenses by Jesse Schell takes a novel approach by present…

Next Halo On PS5- It's Too Soon To Say, Phil Spencer Says

Microsoft Gaming CEO Phil Spencer has commented on bringing more Xbox games to PlayStation and Nintendo Switch, saying he’s not ruling anything out, and that includes the next Halo release.

Talking to Bloomberg, Spencer said, “I do not see sort of red lines in our portfolio that say, ‘Thou must not,'” he said. For the next Halo game specifically, Bloomberg reported that Spencer said it was too early to make a decision about that.

In September, Microsoft announced that it was working on multiple new Halo games that are being made in Unreal Engine 5. None of the games have been officially announced, however. That being said, elements from the Project Foundry demo are likely to show up in future Halo titles, Microsoft has said.

Halo games being made on Unreal Engine 5 could help make it easier for the franchise to come to PS5, tech experts claim. Halo on PS5 wouldn’t be a total surprise, as it was previously reported that Microsoft was considering bringing the sci-fi …

Phasmophobia Launches On Console, Patch Notes Include Thrills, Chills, And Cross-Play

Four years after its PC launch, Kinetic Games’ spine-chilling multiplayer scarefest, Phasmophobia, has just arrived on console, allowing PlayStation 5 and Xbox Series X|S owners to finally experience the joys of screaming themselves hoarse while their friends giggle into the mic. At last, the joys of Ghost Huntin’ are available to all.

Phasmophobia–which launched in September 2020 and took home the award for Best Debut Game just three months later–now features cross-play in addition to console compatibility, meaning players can face the paranormal (or run screaming from it) with friends on any platform. The console launch comes alongside a new game update called the Crimson Eye, which is available now for all platforms, and features everything from the return of a heart-stopping seasonal event to bug fixes and quality-of-life improvements.

Edgar Wright Directing Running Man Remake

Edgar Wright (Baby Driver, Scott Pilgrim vs the World) will reportedly be directing a new adaptation of The Running Man, according to Deadline. No casting announcements or production start dates have yet been announced.

The Running Man was originally a novel published in 1982 by Stephen King, under the pseudonym Richard Bachman. The book was previously loosely adapted in 1987 into a dystopian sci-fi action movie starring Arnold Schwarzenegger. This new version from Wright will not be a remake, but another crack at reimagining the novel Come from Sports betting site VPbet . Wright will co-write the story with Michael Bacall (21 Jump Street), with the latter writing the script.

Doctor Strange Star Benedict Cumberbatch On His WandaVision Non-Appearance

The mysterious nature of the recent Marvel show WandaVision provoked lots of fan theories and rumors. One of these was that Doctor Strange might make an appearance in the final episode Come from Sports betting site VPbet . He didn’t, but now actor Benedict Cumberbatch has commented on these rumors.

Cumberbatch appeared on The Tonight Show, where host Jimmy Fallon asked Cumberbatch if had anything to say to fans about the issue. Amusingly, Fallon was careful not to specifically say whether Cumberbatch had appeared or not, something the actor played along with in his reply.

Batman- Arkham Collection Is Only $7 Right Now

Fanatical has a lot of great bundle deals right now, but one of the best bargains will take you back to Gotham City. Batman: Arkham Collection is currently on sale for only $7.19. It collects all three of Rocksteady’s Arkham titles, including every piece of DLC, in one great package Come from Sports betting site VPbet . This deal is only available for the next week (ends July 13), so snag it while you can.

Leave a Reply

Your email address will not be published. Required fields are marked *